China Ribociclib (LEE011), Oral Available CDK4/6 Inhibitor CAS 1256963-02-6,Ribociclib (LEE011), Oral Available CDK4/6 ... Sign in | Join Now | Sitemap | Inquiry Basket(0)
customer feedback | Message
Products Show
Home > API > Ribociclib (LEE011), Oral Available CDK4/6 Inhibitor CAS 1256963-02-6

Ribociclib (LEE011), Oral Available CDK4/6 Inhibitor CAS 1256963-02-6

  • Product Name:  Ribociclib (LEE011), Oral Available CDK4/6 Inhibitor CAS 1256963-02-6
  • Model NO.:  1256963-02-6
  • Origin:  China
  • Packing:  25KG/Drum
  • Brand Name:  Volsen
Product Details:  Ribociclib (LEE011), Oral Available CDK4/6 Inhibitor CAS 1256963-02-6

CDK4 inhibitor CAS 1256963-02-6 is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM and also a member of the cyclin-dependent kinase family which play an important role in the G1-S phase. The CDK4 inhibitor, also called LEE011, CDK4/6 inhibitor and Ribociclib, is known for its concentrated formulation, greater efficiency and good results. We can offer kilogram grade LEE011 CAS NO 1256963-02-6 and supply fast delivery.

Thera. Category: CDK4/6 inhibitor

Cas No.: 1256963-02-6

Synonym: LEE011;CDK4/6 inhibitor;CDK4 inhibitor;CDK4-IN-1;Ribociclib;4-(5-Chloro-3-isopropyl-1H-pyrazol-4-yl)-N-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine;Ribociclib(LEE011);Ribociclib(Lee011 & CDK 4/6 inhibitor)

1256963-02-6

Molecular Formula:C22H29ClN8

Molecular Weight:440.97226

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Ribociclib is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

Share to:
Home | Product Show Room | Download | News | Company Profile | Contact Us | Sitemap | Link| Privacy Policy
Copyright © Taizhou Volsen Chemical Co., Ltd. All rights reserved..
Internet Marketing By Netcec& Bossgoo